Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The British Journal of Ophthalmology|October 24, 2001
Correction of refractive error in the Victorian population: the feasibility of "off the shelf" spectaclesR Maini, J Keeffe, L A Weih, et al.
Clinical and Experimental Immunology|August 1, 1990
Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell culturesF M Brennan, D Chantry, M Turner, et al.
Annals of Vascular Surgery|December 1, 1987
Experimental and clinical experience with a gelatin impregnated Dacron prosthesisJ K Drury, T R Ashton, J D Cunningham, et al.
Immunology Today|March 1, 1992
T-cell-targeted immunotherapyM Feldmann, C H June, A McMichael, et al.
Annals of Biomedical Engineering|January 1, 1986
New polyester arterial prostheses from Great Britain: an in vitro and in vivo evaluationR G Guidoin, M King, M Marois, et al.
Artificial Organs|April 1, 1986
Repeated membrane plasma separation with on-line sorbent treatment of plasma in the conscious ratC J Ryan, C D Pusey, M Aslam, et al.
Clinical and Experimental Immunology|January 1, 1994
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitisA G Zaman, C Edelsten, M R Stanford, et al.
European Journal of Immunology|November 1, 1988
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritisT Hirano, T Matsuda, M Turner, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 24, 2012
Travel-associated Legionnaires disease in residents from England and Wales travelling to Corfu, Greece, August to October 2011R Maini, F Naik, T g Harrison, et al.
Lancet (London, England)|January 6, 2000
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study GroupR Maini, E W St Clair, F Breedveld, et al.
Pageof 3